SI-BONE (SIBN) News Today $13.05 -0.31 (-2.32%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$13.06 +0.00 (+0.04%) As of 04/15/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Trexquant Investment LP Invests $1.23 Million in SI-BONE, Inc. (NASDAQ:SIBN)Trexquant Investment LP acquired a new position in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 87,783 shares of the company's stockApril 13 at 4:39 AM | marketbeat.comWellington Management Group LLP Lowers Position in SI-BONE, Inc. (NASDAQ:SIBN)Wellington Management Group LLP cut its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 50.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 504,687 shares of the company's stock after selling 523,551 sharesApril 13 at 4:19 AM | marketbeat.comSI-Bone price target lowered to $20 from $22 at TruistApril 12, 2025 | markets.businessinsider.comSI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue GrowerApril 8, 2025 | seekingalpha.comSI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $46,850.65 in StockApril 8, 2025 | americanbankingnews.comSI-BONE, Inc. (NASDAQ:SIBN) SVP Sells $44,229.92 in StockApril 6, 2025 | insidertrades.comSI-BONE, Inc. (NASDAQ:SIBN) SVP Michael A. Pisetsky Sells 3,128 SharesSI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) SVP Michael A. Pisetsky sold 3,128 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $14.14, for a total value of $44,229.92. Following the sale, the senior vice president now owns 244,878 shares in the company, valued at $3,462,574.92. The trade was a 1.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.April 6, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells 3,311 Shares of StockSI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) insider Anthony J. Recupero sold 3,311 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.15, for a total transaction of $46,850.65. Following the completion of the sale, the insider now owns 284,555 shares in the company, valued at approximately $4,026,453.25. The trade was a 1.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.April 6, 2025 | marketbeat.comRaymond James Financial Inc. Buys New Shares in SI-BONE, Inc. (NASDAQ:SIBN)Raymond James Financial Inc. purchased a new position in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 87,920 shares of the company's stock, valued at approxiApril 4, 2025 | marketbeat.comShort Interest in SI-BONE, Inc. (NASDAQ:SIBN) Rises By 40.5%SI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,770,000 shares, a growth of 40.5% from the February 28th total of 1,260,000 shares. Based on an average daily volume of 382,900 shares, the short-interest ratio is currently 4.6 days. Approximately 4.4% of the company's stock are short sold.March 31, 2025 | marketbeat.comAmerican Century Companies Inc. Raises Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)American Century Companies Inc. boosted its position in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 11.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,378,068 shares of the company's stock aftMarch 30, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Shares Gap Up - Here's What HappenedSI-BONE (NASDAQ:SIBN) Shares Gap Up - Time to Buy?March 26, 2025 | marketbeat.comShort Interest in SI-BONE, Inc. (NASDAQ:SIBN) Expands By 17.8%SI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,260,000 shares, an increase of 17.8% from the February 13th total of 1,070,000 shares. Based on an average trading volume of 364,300 shares, the days-to-cover ratio is presently 3.5 days. Currently, 3.1% of the company's stock are short sold.March 20, 2025 | marketbeat.comTocqueville Asset Management L.P. Purchases Shares of 170,000 SI-BONE, Inc. (NASDAQ:SIBN)Tocqueville Asset Management L.P. acquired a new position in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 170,000 shares of the company's stock, valueMarch 19, 2025 | marketbeat.comFirst Eagle Investment Management LLC Makes New Investment in SI-BONE, Inc. (NASDAQ:SIBN)First Eagle Investment Management LLC bought a new stake in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 185,448 shares of the company's stock, valued atMarch 17, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. decreased its stake in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 11.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 407,378 shares of the company's stock after sellingMarch 15, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Essex Investment Management Co. LLCEssex Investment Management Co. LLC boosted its holdings in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 24.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 208,160 shares of the company's stockMarch 10, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund lowered its stake in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 72.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,135 shares of the company's stock after selMarch 6, 2025 | marketbeat.comSI-BONE, Inc. 2024 Q4 - Results - Earnings Call PresentationMarch 4, 2025 | seekingalpha.comSI-BONE, Inc. (NASDAQ:SIBN) Receives Consensus Rating of "Buy" from AnalystsShares of SI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) have received a consensus recommendation of "Buy" from the six ratings firms that are covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among brMarch 3, 2025 | marketbeat.comVELA Investment Management LLC Boosts Holdings in SI-BONE, Inc. (NASDAQ:SIBN)VELA Investment Management LLC boosted its holdings in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 23.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 122,671 shares of the company's stock after buying an additional 23,592 shares duringMarch 1, 2025 | marketbeat.comSI-BONE FY2025 EPS Forecast Decreased by Cantor FitzgeraldSI-BONE, Inc. (NASDAQ:SIBN - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for shares of SI-BONE in a research note issued to investors on Tuesday, February 25th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will earn ($0.64) pFebruary 28, 2025 | marketbeat.comQ4 2024 SI-BONE Inc Earnings CallFebruary 26, 2025 | uk.finance.yahoo.comSI-BONE (NASDAQ:SIBN) Reaches New 1-Year High on Analyst UpgradeSI-BONE (NASDAQ:SIBN) Hits New 1-Year High After Analyst UpgradeFebruary 26, 2025 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on SI-Bone (SIBN)February 25, 2025 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on SI-Bone (SIBN)February 25, 2025 | markets.businessinsider.comSI-BONE, Inc. (NASDAQ:SIBN) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | msn.comTruist Financial Reiterates "Buy" Rating for SI-BONE (NASDAQ:SIBN)Truist Financial reissued a "buy" rating and issued a $22.00 target price (up previously from $18.00) on shares of SI-BONE in a report on Tuesday.February 25, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Shares Gap Up After Better-Than-Expected EarningsSI-BONE (NASDAQ:SIBN) Shares Gap Up After Better-Than-Expected EarningsFebruary 25, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Receives "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and issued a $25.00 price target on shares of SI-BONE in a report on Tuesday.February 25, 2025 | marketbeat.comNeedham & Company LLC Forecasts Strong Price Appreciation for SI-BONE (NASDAQ:SIBN) StockNeedham & Company LLC increased their price target on shares of SI-BONE from $20.00 to $24.00 and gave the stock a "buy" rating in a research note on Tuesday.February 25, 2025 | marketbeat.comSI-Bone reports Q4 EPS (11c), consensus (13c)February 25, 2025 | markets.businessinsider.comSI-BONE, Inc. (SIBN) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comSI-Bone sees FY25 revenue $193.5M-$195.5M, consensus $193.47MFebruary 25, 2025 | markets.businessinsider.comSI-BONE (NASDAQ:SIBN) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPSSI-BONE (NASDAQ:SIBN - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.05. SI-BONE had a negative net margin of 23.82% and a negative return on equity of 22.51%.February 24, 2025 | marketbeat.comSI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 GuidanceFebruary 24, 2025 | globenewswire.comSI-BONE Inc (SIBN) Q4 2024: Everything You Need To Know Ahead Of EarningsFebruary 23, 2025 | finance.yahoo.comBruker Appoints Laura Francis to its Board of DirectorsFebruary 21, 2025 | finance.yahoo.comSI-BONE (NASDAQ:SIBN) Sees Large Volume Increase - Still a Buy?SI-BONE (NASDAQ:SIBN) Sees Strong Trading Volume - Still a Buy?February 19, 2025 | marketbeat.comSI-BONE (SIBN) to Release Earnings on MondaySI-BONE (NASDAQ:SIBN) will be releasing earnings after the market closes on Monday, February 24, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661845)February 17, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Given Average Rating of "Buy" by AnalystsShares of SI-BONE, Inc. (NASDAQ:SIBN - Get Free Report) have been assigned a consensus rating of "Buy" from the six brokerages that are covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month target price amoFebruary 6, 2025 | marketbeat.comSi-Bone director Jeffrey W. Dunn sells $5,562 in common stockFebruary 5, 2025 | msn.comSI-BONE (NASDAQ:SIBN) shareholders have endured a 20% loss from investing in the stock five years agoFebruary 5, 2025 | uk.finance.yahoo.comSI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025February 3, 2025 | globenewswire.comCantor Fitzgerald Expects Stronger Earnings for SI-BONESI-BONE, Inc. (NASDAQ:SIBN - Free Report) - Research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for shares of SI-BONE in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now expects that the company will earn ($0.65) per share fJanuary 23, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN)JPMorgan Chase & Co. grew its holdings in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 14.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 177,793 shares of the company's stock after buying an additional 22,732 shares during the quarter. JPMorgaJanuary 21, 2025 | marketbeat.comSI-Bone price target raised to $20 from $19 at NeedhamJanuary 17, 2025 | markets.businessinsider.comSI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024January 15, 2025 | finanznachrichten.deSI-Bone’s Robust Growth and Market Potential Justify Buy RatingJanuary 15, 2025 | markets.businessinsider.comTruist Financial Keeps Their Buy Rating on SI-Bone (SIBN)January 15, 2025 | markets.businessinsider.com Remove Ads Get SI-BONE News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Media Mentions By Week SIBN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIBN News Sentiment▼0.760.79▲Average Medical News Sentiment SIBN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIBN Articles This Week▼53▲SIBN Articles Average Week Remove Ads Get SI-BONE News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LivaNova News Today LeMaitre Vascular News Today Enovis News Today NovoCure News Today CONMED News Today Warby Parker News Today Cadre News Today Kestra Medical Technologies News Today Liquidia News Today Tandem Diabetes Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SIBN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
